Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did.Read how

US STOCKS-Wall Street buys the dip as investors bet on stimulus

Published 02/03/2020, 20:34
Updated 02/03/2020, 20:36
© Reuters.  US STOCKS-Wall Street buys the dip as investors bet on stimulus

* Indexes surge: Dow 2.98%, S&P 500 2.40%, Nasdaq 2.30%

* Tech sector biggest boost, Apple up over 6%

* Forty Seven Inc hits record high on $4.9 bln offer

(Updates to afternoon)

By Noel Randewich

March 2 (Reuters) - Wall Street surged on Monday as

investors hunted for bargains following reassurances by central

banks that they stood ready to counter the economic impact from

the coronavirus following last week's steep sell-off.

Apple AAPL.O bounced back from a two-year low to jump 6.3%

and lift the S&P 500 more than any other company.

The S&P 500 was on track for its best one-day gain in over a

year. That followed the U.S. stock market's worst week since the

2008 financial crisis, sinking into correction territory on

Thursday due to fears of a recession resulting from the

epidemic.

Bank of Japan Governor Haruhiko Kuroda said on Monday that

Japan's central bank would take necessary steps to stabilize

financial markets. That followed a similar move by Fed Chair

Jerome Powell last Friday. "We can shrug off an economic downturn, but if it starts to

spill into companies' capacity to pay their debts, then that

creates deeper problems. But it seems to me like the central

banks are linking arms to find a way to insulate the credit

markets from economic uncertainty," said Jack Ablin, Chief

Investment Officer at Cresset Wealth Advisors in Chicago.

Traders see a 100% chance of a 50 basis point rate cut at

the Fed's March meeting, according to CME Group's FedWatch tool.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

At 2:06 p.m. ET, the Dow Jones Industrial Average .DJI was

up 2.98% at 26,167.45 points, while the S&P 500 .SPX surged

2.40% to 3,025.12.

The Nasdaq Composite .IXIC added 2.3% to 8,764.71.

"The sell-off was so fierce last week that you do have some

buy-the-dip investors emerging," said Brent Schutte, chief

investment strategist, Northwestern Mutual Wealth Management

Company.

The Institute for Supply Management said domestic

manufacturing activity barely expanded last month due to supply

issues stemming from the virus outbreak. "The Fed can cut rates all it wants, that is not going to

put a person in a factory producing a product if that person is

quarantined," said Randy Frederick, vice president of trading

and derivatives for Charles Schwab in Austin, Texas.

"I don't think (monetary policy) solves the problem ... This

particular one is both supply and demand, it will help but it

won't fix the problem."

Cancer drug developer Forty Seven Inc FTSV.O jumped 61%

after larger peer Gilead Sciences GILD.O made a $4.9 billion

offer for the firm. Gilead rose 6.7%. Surgical mask maker Alpha Pro Tech Ltd APT.N tumbled 23%

but remains up 360% year-to-date.

Advancing issues outnumbered declining ones on the NYSE by a

3.12-to-1 ratio; on Nasdaq, a 2.08-to-1 ratio favored advancers.

The S&P 500 posted no new 52-week highs and 17 new lows; the

Nasdaq Composite recorded 23 new highs and 121 new lows.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.